CD19 and systemic lupus erythematosus: Since aNAV B cells were found to be expanded in total CD19+ B cells and DNA tetramer-binding B cells of SLE patients, we hypothesized that the frequency of this subset correlated with clinical parameters and that aNAV B cells could be biomarkers for monitoring disease activity.